Literature DB >> 24472290

Pheochromocytoma: a review.

A Tsirlin1, Y Oo1, R Sharma2, A Kansara1, A Gliwa1, M A Banerji1.   

Abstract

Pheochromocytomas are catecholamine producing neuroendocrine tumors that can be adrenal or extra-adrenal in origin. The classic symptoms of pheochromocytoma are headache, palpitation, anxiety and diaphoresis and the tumor can occur at any age with equal gender distribution. In patients with an established mutation or hereditary syndrome the condition may manifest at a younger age than in those with sporadic disease. Pheochromocytoma can be associated with certain genetic syndromes such as multiple endocrine neoplasia type 2 (MEN 2), neurofibromatosis (NF) and von Hippel-Lindau (VHL) syndrome. Pheochromocytoma is diagnosed with biochemical confirmation of hormonal excess followed by anatomical localization (CT or MRI). The mainstay of definitive therapy is surgical resection. In this review, we discuss in detail about the symptomatology, diagnosis, genetic aspects and management of pheochromocytoma.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adrenal gland; Catecholamines; Paraganglioma; Pheochromocytoma

Mesh:

Substances:

Year:  2014        PMID: 24472290     DOI: 10.1016/j.maturitas.2013.12.009

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  34 in total

Review 1.  Inhibition of Cdc42 and Rac1 activities in pheochromocytoma, the adrenal medulla tumor.

Authors:  Pauline Croisé; Laurent Brunaud; Petra Tóth; Stéphane Gasman; Stéphane Ory
Journal:  Small GTPases       Date:  2016-06-29

2.  A large mesenteric paraganglioma with lymphovascular invasion.

Authors:  Mohd Afiq Mohd Slim; Susan Yoong; William Wallace; Keith Gardiner
Journal:  BMJ Case Rep       Date:  2015-05-12

Review 3.  Pheochromocytomas and Hypertension.

Authors:  Joseph M Pappachan; Nyo Nyo Tun; Ganesan Arunagirinathan; Ravinder Sodi; Fahmy W F Hanna
Journal:  Curr Hypertens Rep       Date:  2018-01-22       Impact factor: 5.369

Review 4.  Molecular Probes, Chemosensors, and Nanosensors for Optical Detection of Biorelevant Molecules and Ions in Aqueous Media and Biofluids.

Authors:  Joana Krämer; Rui Kang; Laura M Grimm; Luisa De Cola; Pierre Picchetti; Frank Biedermann
Journal:  Chem Rev       Date:  2022-01-07       Impact factor: 60.622

5.  Concomitant Existence of Bilateral Adrenal Adenomas. To Operate or Not?

Authors:  Christos Damaskos; Nikolaos Garmpis; Dimitrios Dimitroulis; Anna Garmpi; Paraskevi Farmaki; Alexandros Patsouras; Vasilili Epameinondas Georgakopoulou; Georgios Kyriakos; Lourdes Victoria Quiles-Sanchez; Athanasios Syllaios; Aliki Liakea; Evangelos Diamantis
Journal:  Maedica (Bucur)       Date:  2021-12

6.  Elemental Composition of Pheochromocytoma Resolved on Solid/Adrenal Tissue and Whole Blood Level.

Authors:  Jovana Jagodić; Branislav Rovčanin; Ivan Paunović; Mladen Mihailović; Nebojša Zečević; Dragan Manojlović; Aleksandar Stojsavljević
Journal:  Biol Trace Elem Res       Date:  2021-10-06       Impact factor: 3.738

Review 7.  The multiple roles of life stress in metabolic disorders.

Authors:  Mika Kivimäki; Alessandro Bartolomucci; Ichiro Kawachi
Journal:  Nat Rev Endocrinol       Date:  2022-10-12       Impact factor: 47.564

8.  Life-threatening conditions of uncommon diagnosis: what can be behind multisystem failure?

Authors:  Said Taharboucht; Lamia Bengherbia; Leila Talbi; Meriem Charifi; Oussama Souas; Ahcene Chibane
Journal:  Intern Emerg Med       Date:  2022-10-18       Impact factor: 5.472

Review 9.  Hypertension in Pheochromocytoma and Paraganglioma: Evaluation and Management in Pediatric Patients.

Authors:  Meredith L Seamon; Ikuyo Yamaguchi
Journal:  Curr Hypertens Rep       Date:  2021-05-27       Impact factor: 5.369

10.  Open abdominal aortic aneurysm repair with incidental finding of an extra-adrenal pheochromocytoma of the organ of Zuckerkandl.

Authors:  Kathy Gonzalez; Michael J Singh
Journal:  Vascular       Date:  2020-08-24       Impact factor: 1.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.